Bravelle with Q-Cap

Bravelle (urofollitropin) is a highly purified preparation of human follicle stimulating (FSH) extracted from the urine of postmenopausal women. Each vial contains 75IU of FSH. Bravelle in conjunction with hCG (human chorionic gonadotropin) is indicated for ovulation induction in patients who have previously received pituitary suppression.